New concepts in drug discovery (2026): Drug residence time
Current Opinion in Structural Biology · 2026-06 · 98 · 103289
DOI: 10.1016/j.sbi.2026.103289 ↗Kurz gefasst
Editorial in der Zeitschrift Current Opinion in Structural Biology, 2026-06. Verfasst von Markus Seeliger und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological Sciences, Renaissance School of Medicine, Stony Brook University, NY 11794, USA; Laufer Center for Physical & Quantitat…. Die Arbeit nennt 14 Literaturangaben. Gefördert von: Center for Cancer Research, National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmacological Sciences, Renaissance School of Medicine, Stony Brook University, NY 11794, USA; Laufer Center for Physical & Quantitative Biology, Stony Brook University, NY 11794, USA. Electronic address…
- Biophysics and Computational Biology Section, Frederick National Laboratory for Cancer Research in the Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD 21702, USA; Department of Human Molecular Gen…
Förderung
- Center for Cancer Research
- National Cancer Institute
- National Institutes of Health
- U.S. Department of Health and Human Services
Zitieren
APA
Seeliger, M., & Nussinov, R. (2026). New concepts in drug discovery (2026): Drug residence time. Current Opinion in Structural Biology, 98, 103289. https://doi.org/10.1016/j.sbi.2026.103289
Vancouver
Seeliger M, Nussinov R. New concepts in drug discovery (2026): Drug residence time. Current Opinion in Structural Biology. 2026;98:103289. doi:10.1016/j.sbi.2026.103289
BibTeX
@article{Seeliger2026,
author = {Seeliger, Markus and Nussinov, Ruth},
title = {New concepts in drug discovery (2026): Drug residence time},
journal = {Current Opinion in Structural Biology},
year = {2026},
volume = {98},
pages = {103289},
doi = {10.1016/j.sbi.2026.103289}
}
EUVIMED